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Caenorhabditis elegans contains two distinct acid
sphingomyelinases
Abstract
Mounting evidence supports a role for acid sphingomyelinase (ASM) in cellular stress signaling. Only
murine and human sphingomyelinases have been defined at the molecular level. These enzymes are the
products of a conserved gene and at the amino acid level share 82% identity. In this study, we show that
the nematode Caenorhabditis elegans possesses two ASMs, termed ASM-1 and ASM-2 encoded by two
distinct genes, but lacks detectable neutral sphingomyelinase activity. The C. elegans ASMs are about
30% identical with each other and with the human and murine enzymes. The conserved regions include
a saposin-like domain, proline-rich domain, and a putative signal peptide. In addition, 16 cysteines
distributed throughout the molecules, and selected glycosylation sites, are conserved. The expression of
these genes in C. elegans is regulated during development. Asm-1 is preferentially expressed in the
embryo, whereas asm-2 is predominantly expressed in postembryonic stages. When transfected as
Flag-tagged proteins into COS-7 cells, ASM-1 is found almost entirely in a secreted form whereas only
20% of ASM-2 is secreted. Only the secreted forms display enzymatic activity. Furthermore, ASM-2
requires addition of Zn2+ to be fully active, whereas ASM-1 is active in the absence of cation. C.
elegans is the first organism to display two ASMs. This finding suggests the existence of an ASM gene
family.
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Mounting evidence supports a role for acid sphingo-
myelinase (ASM) in cellular stress signaling. Only mu-
rine and human sphingomyelinases have been defined
at the molecular level. These enzymes are the products
of a conserved gene and at the amino acid level share
82% identity. In this study, we show that the nematode
Caenorhabditis elegans possesses two ASMs, termed
ASM-1 and ASM-2 encoded by two distinct genes, but
lacks detectable neutral sphingomyelinase activity. The
C. elegans ASMs are about 30% identical with each other
and with the human and murine enzymes. The con-
served regions include a saposin-like domain, proline-
rich domain, and a putative signal peptide. In addition,
16 cysteines distributed throughout the molecules, and
selected glycosylation sites, are conserved. The expres-
sion of these genes in C. elegans is regulated during
development. Asm-1 is preferentially expressed in the
embryo, whereas asm-2 is predominantly expressed in
postembryonic stages. When transfected as Flag-tagged
proteins into COS-7 cells, ASM-1 is found almost entirely
in a secreted form whereas only 20% of ASM-2 is se-
creted. Only the secreted forms display enzymatic activ-
ity. Furthermore, ASM-2 requires addition of Zn21 to be
fully active, whereas ASM-1 is active in the absence of
cation. C. elegans is the first organism to display two
ASMs. This finding suggests the existence of an ASM
gene family.
The sphingomyelin pathway is an ubiquitous signaling sys-
tem linking a specific set of cell surface receptors and environ-
mental stresses through to the intracellular signaling appara-
tus (1). This pathway is initiated by hydrolysis of the
phospholipid sphingomyelin (N-acylsphingosine-1-phosphocho-
line) which is preferentially concentrated in the plasma mem-
brane of mammalian cells (2). Sphingomyelin hydrolysis occurs
via the action of sphingomyelin specific forms of phospholipase
C, termed sphingomyelinases (sphingomyelin phosphodiester-
ases; EC 3.1.4.12). Ceramide, generated by this reaction, acts
as a second messenger and initiates cell type specific signaling.
Sphingomyelinases are categorized as alkaline, neutral, or
acid according to their pH optima. Alkaline sphingomyelinase
is found mostly in intestinal mucosa and bile (3–5). Alkaline
sphingomyelinase possesses an optimum pH at 9 and is Zn21-
and Mg21-independent. Alkaline sphingomyelinase may play a
role in the digestion of dietary sphingomyelin. A neutral sphin-
gomyelinase is found in many, if not all, tissues. The neutral
sphingomyelinase is membrane-bound, Mg21-dependent, and
displays a pH optimum of 7.4 (6). The gene encoding the mam-
malian neutral sphingomyelinase is yet to be identified. In
addition to the membrane-bound form, a cytosolic cation-inde-
pendent form of neutral sphingomyelinase has been described
(7).
ASM,1 possessing optimum pH between 4.5 and 5.5, is found
in all mammalian cells (8). The human and murine ASMs are
the products of a conserved gene and at the amino acid level
share 82% identity. The hASM gene encodes a 629-amino acid
glycoprotein with a calculated molecular mass of 64 kDa (9).
Human ASM contains a signal sequence at the N terminus
comprised of five leucine-alanine repeats. This signal peptide
may present a hydrophobic core and play a role in targeting the
ASM into the endoplasmic reticulum. There are six potential
N-linked glycosylation sites (amino acids 86, 175, 335, 395, 503,
and 520, respectively) in hASM. Site-directed mutagenesis
studies show that five of these sites (amino acid 86, 175, 335,
395, and 520) are glycosylated in COS-1 cells (10). Elimination
of any of these sites results in various degrees of decreased
enzyme activity. A similar result is found in the murine ASM
(11). An N-terminal region of the hASM (residues 89–165) is
found to be highly homologous to the sphingolipid activator
protein saposin and may possess lipid-binding and/or sphingo-
myelinase activator properties (12). Within this saposin-like
domain are six cysteine residues (residues 89, 92, 120, 131, 157,
and 165) that may participate in formation of intramolecular
disulfide bridges. A proline-rich domain (amino acid 182–197)
is located immediately after the second glycosylation site and
may act as a flexible hinge region linking the activation domain
(saposin-like domain) and the C-terminal putative enzymatic
domain.
ASMs are found in cellular and secreted forms in mamma-
lian cells (13). This appears to reflect post-translational proc-
essing of the primary gene product. The secreted form of ASM
is Zn21 stimulated. In contrast, the lysosomal form is not Zn21
stimulable, which may result from acquisition of cellular Zn21
during the lysosomal targeting process (13). Mammalian ASM
is subject to substantial post-translational proteolysis. Sand-
hoff and co-workers (14) found that the sphingomyelinase gene
product manifests an apparent molecular mass of 75 kDa in
SDS-PAGE, and is subsequently processed to a 72-kDa form or
alternately to a 57-kDa form. All three forms are found in
COS-1 cell lysates. Tabas and co-workers (15) found that
macrophages, fibroblasts, and endothelial cells secrete sub-
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stantial amounts of the high molecular weight form of ASM.
Secretion of this form is increased by cytokine stimulation,
perhaps by increasing the flux of the ASM precursor through
the Golgi-secretory pathway. There is emerging evidence sug-
gesting that caveolae, putative plasma membrane microdo-
mains, may be important sites for ligand-induced sphingomy-
elin hydrolysis via ASM (16).
ASM has been shown to be involved in cytokine and cellular
stress signaling cascades. A number of studies showed that
CD95 and the 55-kDa tumor necrosis factor receptor activate
ASM during induction of apoptosis, perhaps via a mechanism
requiring the death domain of these receptors (17, 18). In vitro,
lymphoblasts from patients with Niemann-Pick disease (NPD),
a genetic deficiency of ASM, and in vivo, endothelium from
ASM knock-out mice, fail to generate ceramide and undergo
apoptosis upon radiation exposure (19). Furthermore, retrovi-
ral transfer of the hASM cDNA into NPD lymphoblasts re-
stored ASM activity into the normal range, and conferred ra-
diation-induced ceramide generation and apoptosis. Similarly,
Debatin and co-workers (18) found that NPD fibroblasts were
deficient in UV- and anthracycline-induced ceramide genera-
tion and apoptosis, and linked ceramide generation to tran-
scriptional up-regulation of CD95 ligand (18). In this regard,
Dong and co-workers (20) found that ASM activity is essential
for UV-induced c-Jun kinase activation, which may be involved
in transcriptional regulation of the apoptotic response. It
should be noted, however, that ceramide can also signal apo-
ptosis in a transcriptionally independent fashion since ceram-
ide signals mitochondrial permeability transition, reactive ox-
ygen species generation and release of apoptosis initiating
factor in cytoplasts from murine 2B4.11 T cells (21). This latter
event is inhibited by anti-apoptotic Bcl-2 family members.
Whether the secreted form of ASM may play a role in stress
signaling is presently uncertain (22).
The nematode Caenorhabditis elegans is an attractive model
for studying signal transduction. C. elegans and mammalian
cells share numerous genes encoding proteins involved in con-
served signal transduction pathways. Some of these pathways,
such as the those involved in vulval development or pro-
grammed cell death, are well defined in C. elegans. However,
the existence of a sphingomyelinase signaling system has not
yet been demonstrated. In fact, no gene or biochemical activity
corresponding to a C. elegans sphingomyelinase has been de-
scribed. In this study, we show that C. elegans possesses two
distinct, evolutionarily related, ASMs.
EXPERIMENTAL PROCEDURES
Materials
DNA restriction and modifying enzymes were purchased from Boeh-
ringer Mannheim (Indianapolis, IN). AmpliTaq DNA polymerase and
rTth DNA polymerase, XL were from Perkin-Elmer (Branchburg, NJ).
Genomyx D-Genozyme Cycle Sequencing Kit was from Genomyx (Fos-
ter City, CA). Random Primers DNA Labeling System was from Life
Technologies, Inc. (Gaitherburg, MD).
Methods
Growing and Handling C. elegans—Bristol (N2) C. elegans was used
throughout these studies and maintained as described previously (23).
Briefly, worms were grown at 22 °C in 60-mm plates containing 3 ml of
nematode growth medium agar carrying a lawn of OP50, a leaky uracil-
requiring strain of Escherichia coli. Worms were harvested by washing
them off the plates with ice-cold 0.1 M NaCl. Dead worms were sepa-
rated by centrifugation in 30% (w/w) sucrose at 600 3 g for 5 min. Live
worms were resuspended in 0.1 M NaCl at 22 °C for 30 min to allow the
complete digestion of bacteria remaining in the nematode guts and then
washed three times with 0.1 M NaCl. Generally, 60 mg of worms can be
recovered from a 60-mm plate.
Cell Culture—COS-7 cells were grown in Dulbecco’s modified Eagle’s
medium containing 10% fetal bovine serum (Life Technologies, Inc.,
Gaitherburg, MD) at 37 °C in a 5% CO2 atmosphere.
Sphingomyelinase Assay—To measure ASM activity, cells or worms
were suspended in 0.2% Triton X-100 and disrupted at 4 °C using a
hand held homogenizer (Kontes, Vineland, NJ) for 2 min. Cells debris
was removed by centrifugation at 600 3 g for 5 min. Lysates were
incubated in ASM assay buffer (250 mM sodium acetate, 0.1% Triton
X-100, pH 5.0) containing various concentrations of [N-methyl-
14C]sphingomyelin (47 mCi/mmol, Amersham Life Science, Arlington
Heights, IL) in a final volume of 60 ml at 37 °C for 1 h. Radioactive
phosphorylcholine was extracted with 200 ml of chloroform:methanol
(2:1, v/v) into the upper aqueous phase and analyzed by scintillation
counting. To measure neutral sphingomyelinase activity, cells or worms
were suspended in a buffer (20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 mM
EDTA, 5 mM dithiothreitol, 0.1 mM Na3VO4, 0.1 mM Na2MoO4, 30 mM
p-nitrophenyl phosphate, 10 mM b-glycerophosphate, 750 mM ATP, 1
mM phenylmethylsulfonyl fluoride, 10 mM leupeptin, 10 mM pepstatin,
and 0.2% Triton X-100), and homogenized and centrifuged as above.
Lysates were incubated in neutral sphingomyelinase assay buffer (20
mM HEPES, pH 7.4, 1 mM MgCl2, 0.1% Triton X-100) containing various
concentrations of [N-methyl-14C]sphingomyelin, and sphingomyelinase
activity was determined as described for ASM assay.
Molecular Cloning of C. elegans ASM Genes—By searching the C.
elegans genomic sequence data base for homologs of the hASM gene, we
identified two regions of genomic DNA that showed significant se-
quence similarity to hASM. These regions were contained within two
predicted genes, B0252.2 (asm-1) and ZK455.4 (asm-2), defined by the
C. elegans sequencing project at Washington University. The cDNA of
asm-1 and asm-2 were cloned by reverse transcription-PCR with primer
pairs flanking the predicted start and stop codons. Briefly, total RNA
from mixed stages of N2 C. elegans was purified using RNAzol (Biotecx,
Houston, TX) according to the manufacturer’s protocol. First strand
cDNA was synthesized by reverse transcriptase using oligo(dT) as
primer (32) and then used as template in PCR using primers flanking
the predicted start and stop codon (asm-1, GAAACTCTGGAAATGAG-
GATAA and TGTACAAGGTCTTTGAAATGAT; and asm-2, TGAAAA-
TACATCTGAGAA and ATGCAGCAGCCTCTCATTATT). The PCR
products were fractionated in agarose gels, excised, and extracted using
the QIAEX GEL Extraction Kit (QIAGEN, Chatsworth, CA). The re-
sulting DNA was cloned into pCRII using the TA cloning system from
Invitrogen (San Diego, CA). The DNA inserts were sequenced using SP6
and T7 primers (24).
Construction of Mammalian Expression Vectors of asm-1 and asm-
2—The Flag epitope tag was introduced at the C terminus of asm-1
cDNA by PCR using T7 primer as the 59 primer and CGGGATCCTA-
CTTGTCATCGTCGTCCTTGTAGTCAAAAGTTGGACAAAG as the 39
primer. The PCR products generated from pCRII/asm-1 were digested
with BamHI and NotI, and the resulting fragment was subcloned into
the mammalian expression vector pCEP4 (Invitrogen, San Diego, CA).
For constructing the asm-2 expression vector, 59 primer (GGGGTACC-
GCCACCATGCAGCAGCCTCTCATTATT) containing the asm-2 start
codon and 39 primer (CCGCTCGAGTCTACTTGTCATCGTCGTCCTT-
GTAGTCTTTTGTTAAATGATCA) with the Flag sequence following the
C terminus sequence of asm-2 were used in PCR to generate the
Flag-tagged asm-2. The Flag-asm-2 sequence was subcloned into
pCEP4 using XhoI and KpnI sites.
Expression of ASM Genes in C. elegans—Mixed stages worms and
eggs, prepared by the method of Sulston and Hodgkin (25), were used
for isolation of total RNA. For Northern blot analysis, 30 mg of RNA was
fractionated on a 1.0% agarose gel in the presence of formaldehyde. The
gel was stained with ethidium bromide to determine the adequacy of
RNA loading. The RNA was transferred to a BA-85 nitrocellulose mem-
brane (Schleicher and Schuell, Keene, NH) with 10 3 SSC. Hybridiza-
tion was carried out using ExpressHyb from CLONTECH Laboratories
(Pine Alto, CA) with [32P]dCTP-labeled full-length asm-1 and asm-2
cDNA as probes. The membrane then was exposed to x-ray film at
280 °C. Molecular weights of the asm transcripts were determined by
comparison to RNA molecular weight markers (Life Technologies, Inc.,
Gaithersburg, MD).
Expression of C. elegans ASMs in COS-7 Cells—COS-7 cells were
transfected using LipofectAMINE (Life Technologies, Inc.) according
the manufacturer’s protocol. At 48 h post-transfection, cell culture
medium was centrifuged at 16,000 3 g for 10 min, and the secreted
Flag-tagged ASM was immunoprecipitated. The cells were lysed in
RIPA buffer (25 mM Tris, pH 7.5, 137 mM NaCl, 10% glycerol, 1%
Nonidet P-40, 2 mM EDTA, 0.1% SDS, and 0.1% deoxycholate) contain-
ing the protease inhibitor mixture tablet Complete (Boehringer Mann-
heim, Indianapolis, IN). The homogenate was spun at 16,000 3 g for 10
min and the supernatant was collected for immunoprecipitation. Flag-
tagged ASM-1 and ASM-2 proteins were immunoprecipitated from the
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medium or cell lysate using the anti-Flag M2 affinity gel (Scientific
Imaging System, New Haven, CT) at 4 °C for 2 h. The beads were
washed six times with Nonidet P-40 buffer (25 mM Tris, pH 7.5, 137 mM
NaCl, 10% glycerol, 1% Nonidet P-40, and 2 mM EDTA) containing the
protease inhibitor mixture tablet. Beads then were resuspended in
sphingomyelinase assay buffer to measure acid or neutral sphingomy-
elinase activities. To estimate the protein content in the enzymatic
reaction, the immunoprecipitate was fractionated on SDS-PAGE, trans-
ferred to nitrocellulose membrane, and stained with colloidal silver.
Then the protein content was estimated by comparison to known quan-
tities of bovine serum albumin standard.
RESULTS
C. elegans Contains Acid but Not Neutral Sphingomyeli-
nase—Prior studies demonstrated that sphingomyelin ac-
counts for 8% of the total phospholipid in C. elegans, suggesting
that enzymes capable of sphingomyelin hydrolysis might exist
in these animals. Table I shows, using an assay optimized for
the mammalian enzyme, that mixed stages C. elegans pos-
sesses ASM activity. The specific activity of the C. elegans ASM
was similar to that of hASM found in HL-60 cells. This ASM
activity is from C. elegans and not due to contamination with E.
coli, since E. coli does not manifest any sphingomyelinase
activity under our experimental conditions (data not shown).
Furthermore, Zn21 (0–10 mM) did not significantly increase
ASM activity in lysates of N2 mixed stages worms (data not
shown). In contrast, C. elegans did not display neutral sphin-
gomyelinase activity in lysates (Table I) or in isolated microso-
mal membrane whether or not ATP, Mg21, or various protease
or phosphatase inhibitors were included in the reaction buffer
(data not shown).
Cloning and Sequence Analysis of Sphingomyelinase Genes
in C. elegans—We found two regions in the C. elegans genomic
DNA containing deduced open reading frames with significant
identity to the human and murine ASM genes. These regions,
found in cosmid B0252.2 located on chromosome II and in
cosmid ZK455.4 located on chromosome X, were designated as
asm-1 and asm-2, respectively. The cDNAs of asm-1 and asm-2
TABLE I
C. elegans possesses acid but not neutral sphingomyelinase activity
Lysates were prepared from mixed stages C. elegans (N2) and HL-60
cells, and sphingomyelinase activity was determined at pH 5.0 and pH
7.4 as described under “Experimental Procedures.”
Enzyme source
Sphingomyelinase activity
pH 5.0 pH 7.4
nmol/mg/h
C. elegans 11.7 6 1.0 0
HL-60 5.7 6 0.1 1.1 6 0.2
FIG. 1. Comparison of C. elegans
and human ASMs. The derived amino
acid sequences of ASM-1 and ASM-2 are
aligned with the sequence of hASM by the
Clustal W. program (30). Identical amino
acids are designated in uppercase,
whereas those conserved between two
sphingomyelinases are designated in low-
ercase. Conserved cysteine residues are
shown in red. Putative N-terminal signal
peptide sequences are in bold italic. The
saposin-like domains are bracketed. Po-
tential proline-rich domains are under-
lined. The conserved glycosylation sites
are shown in light blue. The boxed amino
acid residues in the hASM are mutated in
NPD and conserved in one or both C. el-
egans ASMs (31).
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were cloned by reverse transcription-PCR as described under
“Experimental Procedures.”
The asm-1 and asm-2 cDNAs contain single large open read-
ing frames which encode polypeptides of 564 and 619 amino
acids, respectively (Fig. 1). Several lines of evidence suggest
that these two coding sequences are complete. 1) Northern blot
analysis using asm-1 or asm-2 cDNA as probes identified both
1.8 and 2.0 kilobase mRNAs, respectively, which correspond to
the lengths of the cloned cDNAs (see below, Fig. 2); 2) Western
blot analysis using a polyclonal antibody generated in rabbits
against full-length hASM, shows that the endogenous ASM-1
and ASM-2 in C. elegans exhibit the same size as their recom-
binant counterpart expressed in COS-7 cells (data not shown);
3) reverse transcription-PCR of the asm-1 mRNA indicated
that the 59 end of this transcript is trans-spliced to a SL1 leader
sequence 12 bases upstream of the putative start codon (data
not shown). Although asm-2 RNA was not trans-spliced to SL1
or SL2, there was no other potential start codon in the genomic
sequence upstream of the predicted initiating methionine (data
not shown). Comparison of the cDNA and genomic sequences
revealed that both asm-1 and asm-2 consist of 11 exons.
The proteins encoded by asm-1 and asm-2 are 32% identical
with each other. Furthermore, ASM-1 and ASM-2 share 30 and
33% identity with hASM, respectively. ASM-1 and ASM-2
share several functional domains with hASM. As in the hASM,
there is a putative secretory signal peptide at the N terminus of
FIG. 2. Sphingomyelinase gene expression in C. elegans. Thirty
mg of total C. elegans RNA from mixed stages (A) and embryos (B) was
electrophoresed in 1.0% agarose gel and transferred to nitrocellulose
membrane. For Northern analysis, RNA was probed with the indicated
cDNA probes and subjected to autoradiography. Data represent one of
two experiments.
FIG. 3. C. elegans ASMs are expressed in both secreted and
cellular forms in COS-7 cells. COS-7 cells were transfected with
pCEP4/asm-1 or pCEP4/asm-2, and after 48 h were homogenized in
buffer as described under “Experimental Procedures.” ASM, quantita-
tively immunoprecipitated from cell lysate (C) and culture medium (S)
using an agarose-conjugated anti-Flag antibody, were resolved by 7.5%
SDS-PAGE, transferred to nitrocellulose membrane, and immuno-
blotted with anti-Flag antibody as described under “Experimental Pro-
cedures.” Data represent one of five experiments.
FIG. 4. The putative C. elegans
sphingomyelinase gene products
possess ASM activity when expressed
in COS-7 cells. COS-7 cells were trans-
fected with pCEP4/asm-1 or pCEP4/
asm-2 and 48 h post-transfection sphingo-
myelinase gene products were
immunoprecipitated from medium as in
Fig. 3. The immunoprecipitate was
washed 6 times with Nonidet P-40 buffer
containing 2 mM EDTA. Sphingomyeli-
nase activity was determined at pH 5.0 in
the presence of 2.0 mM ZnCl2 as described
under “Experimental Procedures.” Data
are presented using the Eadee-Hofstee
transformation. The units of velocity (Vo)
are millimole/mg of protein/h, and sub-
strate concentration (S) is millimolar.
These data represent one of two similar
experiments.
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both ASM-1 and ASM-2 (Fig. 1, italicized). Furthermore, 16
cysteine residues dispersed throughout the protein sequence
are highly conserved between the hASM, ASM-1, and ASM-2
(in red). Similar to the hASM, ASM-1 and ASM-2 possess a
saposin-like domain (bracketed) in the N terminus followed by
a proline-rich domain (underlined; truncated in ASM-1). Seven
putative N-linked glycosylation sites are found in ASM-1,
whereas five are found in ASM-2. Among these N-linked gly-
cosylation sites, site 351 in ASM-1 and sites 159 and 523 in
ASM-2 are conserved with respect to the human sequence.
Developmental Expression of asm-1 and asm-2—Although
the human and murine ASM genes have been cloned, their
developmental pattern remains largely unknown. To study
ASM gene expression in C. elegans, we isolated total RNA from
wild type (either embryos or mixed stages) animals and per-
formed Northern blot analysis using asm-1 or asm-2 cDNA as
probe. The asm-1 probe detected a 1.8-kilobase transcript that
was expressed at a higher level in embryos than in the mixed
stages samples (Fig. 2, top). In contrast, the 2.0-kilobase asm-2
transcript appears to be preferentially expressed during post-
embryonic development, as it was not detectable in embryos
(Fig. 2, middle). Smaller bands, observed below the primary
asm-1 and asm-2 bands, may represent alternative spliced
transcripts.
ASM-1 and ASM-2 Are Both Secretory Enzymes—In order to
study whether the gene products of asm-1 and asm-2 exhibit
sphingomyelinase activity, these cDNAs were cloned into the
mammalian expression vector pCEP4 and overexpressed as
Flag-tagged proteins in COS-7 cells. Mammalian ASM can be
detected as intracellular and secreted forms (13, 14). We there-
fore checked whether ASM-1 or ASM-2 might also be secreted.
Flag-ASM-1 was found exclusively in the cell culture medium
by Western blot analysis (Fig. 3). In contrast, only one-fifth of
the Flag-ASM-2 was secreted. Similar to the mammalian en-
zymes, the form of Flag-ASM-2 found in the cell culture me-
dium exhibited higher apparent molecular weight than its in-
tracellular counterpart. Furthermore, the apparent molecular
weights in SDS-PAGE of both Flag-ASM-1 and Flag-ASM-2 are
higher than their calculated molecular weights, consistent with
post-translational modification such as glycosylation.
The overexpressed recombinant proteins from cell culture
medium were immunoprecipitated and the enzymatic activities
assayed under various conditions. Eadee-Hofstee transforma-
tion of kinetic data shows that at pH 5.0, both ASM-1 and
ASM-2 hydrolyzed sphingomyelin to ceramide (Fig. 4). How-
ever, sphingomyelinase activity was not found at pH 7.4 or pH
9.0, indicating these two enzymes are ASMs, as anticipated
from their primary sequence similarity to hASM (Table II).
Whereas the Km of Flag-ASM-2 is 3-fold higher than that of
Flag-ASM-1, the Vmax of Flag-ASM-1 is 3 orders of magnitude
higher than that of Flag-ASM-2 (Table II). It should be noted
that these kinetic data were obtained using 2.0 mM ZnCl2. In
the presence of 10.0 mM ZnCl2 the Vmax of ASM-2 is approxi-
mately 60% higher.
In contrast, intracellular Flag-ASM-2 did not manifest enzy-
matic activity, whether in the presence or absence of detergents
(Triton X-100, Nonidet P-40, or SDS). To exclude the possibility
of a selective inhibitory effect of the sodium acetate buffer used
in the assay on the intracellular form of ASM-2, we repeated
the assay in a sodium citrate buffer which also did not yield any
activity (data not shown). Furthermore, neither ATP, Zn21,
Mg21, nor Ca21 conferred ASM activity onto the intracellular
form of ASM-2. To test whether COS-7 cells contain an inhib-
itor of ASM-2, we added a lysate of COS-7 cells to the assay
containing immunoprecipitated secreted Flag-ASM-2. Whether
or not 10 mM Zn21 was included in the buffer, the lysate failed
TABLE II
ASM-1 and ASM-2 are acid sphingomyelinases
COS-7 cells were transfected with pCEP4/ASM-1 or pCEP4/ASM-2.
At 48 h post-transfection, Flag-ASM-1 and Flag-ASM-2 were immuno-
precipitated from cell culture medium with anti-Flag-agarose and
washed 6 times with Nonidet P-40 buffer containing 2 mM EDTA.
Sphingomyelinase activity was determined at various of pH in the
presence of 2.0 mM ZnCl21 as described under “Experimental Proce-
dures.”
pH 5.0 pH 7.4 pH 9.0
Vmax
a Km
b Vmax Km Vmax Km
ASM-1 2.9 92 0 NAc 0 NA
ASM-2 4.8 3 1023 288 0 NA 0 NA
a Vmax units are mmol/mg/h.
b Km units are mM.
c NA, not applicable.
FIG. 5. Effect of Zn21 on C. elegans ASM activity. ASMs were
immunoprecipitated as in Fig. 4 from COS-7 cells transfected with
pCEP4/asm-1 (closed symbols) or pCEP4/asm-2 (open symbols). Sphin-
gomyelinase activity was determined with varying concentrations of
ZnCl2 as described under “Experimental Procedures.” Data are repre-
sentative of two experiments.
FIG. 6. Effects of divalent cations on C. elegans ASM activity.
ASMs from COS-7 cells, transfected with pCEP4/asm-1 (solid bars) or
pCEP4/asm-2 (stippled bars), were immunoprecipitated as in Fig. 4.
Sphingomyelinase activity was determined in the presence of 20.0 mM
of cations as described under “Experimental Procedures.” Data are
representative of two experiments.
C. elegans Contains Two Acid Sphingomyelinases14378
 at H
auptbibliothek Universitaet Zuerich Irchel. Bereich Forschung on O









to inhibit the activity of secreted Flag-ASM-2 (data not shown).
In fact, the lysate minimally enhanced ASM-2 activity. Thus,
the inability to detect intracellular ASM-2 activity does not
result from an endogenous inhibitor in COS-7 cells. These
studies suggest that either the intracellular form of ASM-2 is
inactive or a necessary co-factor specific for C. elegans ASM-2 is
absent. Furthermore, at all Zn21 concentrations (0–10 mM),
embryo lysates manifested 1.78 6 0.12 (mean 6 S.E.)-fold
higher ASM activity than mixed stages lysates, consistent with
the apparent specific activities and developmental expression
of asm-1 and asm-2.
Metal Ion Requirement—Previous investigations showed
that the secreted form of hASM was quite sensitive to EDTA
due to Zn21 depletion (26). Characterization of ASM-1 and
ASM-2 revealed that Zn21 increased the ASM-2 activity in a
dose-dependent manner, but had no effect on ASM-1 (Fig. 5).
The effects of four other cations on ASM-1 and ASM-2 activity
were tested, none of which showed stimulatory effects (Fig. 6).
DISCUSSION
In this study, we have shown that C. elegans possesses two
distinct ASMs, encoded by two separate but homologous genes.
These enzymes are about 30% identical with each other and
with the human and murine enzymes. The expression of these
two genes in C. elegans is regulated during development. asm-1
is preferentially expressed in embryos whereas asm-2 is pref-
erentially expressed during post-embryonic development. This
suggests that in addition to any housekeeping function which
might be involved in lipid metabolism, these sphingomyeli-
nases may play distinct roles in signaling. C. elegans is the first
organism to display two ASMs.
Despite extensive investigation into the role of ASM in sig-
naling and NPD, little is known about the relationship between
the structure and function of this enzyme. Human and murine
ASM share 82% identity, which limits the use of an alignment
analysis to define functional domains. Alternately, phospho-
lipases C from in Staphylococcus, Clostridium perfringens, and
Bacillus cereus, which exhibit some activity toward sphingo-
myelin (27–29), share no homology with their mammalian
counterparts. The presence of conserved signal peptides, cys-
teine residues, proline-rich regions, and N-linked glycosylation
sites between mammalian and nematode enzymes suggest
these regions are critical for these enzymes to function as
ASMs.
Tabas and co-workers reported that ASM is secreted from
various cell types and that secretion is regulated by cytokine
stimulation (15). Our data are consistent with their findings, as
Flag-ASM-1 and Flag-ASM-2 are both secreted from COS-7
cells. Furthermore, Flag-ASM-2, like the secreted mammalian
enzyme, appears to be activated by Zn21. In contrast, Flag-
ASM-1 is fully active upon secretion independent of Zn21 sug-
gesting that activation of Flag-ASM-1 occurs by an alternate
mechanism.
Prior to the present investigation, there existed only one
ASM gene conserved between mouse and man. The present
investigations add two new ASMs, suggesting the possible ex-
istence of a gene family. By comparing the action of the two C.
elegans sphingomyelinases to their mammalian counterpart, it
may be possible to delineate important information concerning
the relationship of structure to function, as well as mechanisms
regulating ASM activity. Finally, C. elegans should provide a
powerful genetic model to study the role of ASM in signal
transduction.
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